Volume 10 Supplement 2

INEBRIA 12th Congress,

Open Access

Screening of problems related to alcohol, tobacco and cannabis in primary care settings: a comparative study between Brazil and Portugal

  • Angela Abreu1Email author,
  • Rafael T Jomar2,
  • Rafaela Costa3,
  • Rachel FS Figueiro1,
  • Maria Helena N Silva1,
  • Pedro Parreira4 and
  • Teresa Barroso4
Addiction Science & Clinical Practice201510(Suppl 2):P2

https://doi.org/10.1186/1940-0640-10-S2-P2

Published: 24 September 2015

Background

The consumption of psychoactive substances is a global health problem.

The objectives are to identify the sample socio-demographic profile and use pattern of alcohol, tobacco and cannabis throughout life and in the last three months. Also, to discuss the application of Brief Intervention procedures for problems related to psychoactive substances in patients assisted at the primary health care, in Brazil (Rio de Janeiro) and Portugal (Coimbra).

Material and methods

The sample included 1700 individuals (Brazil, n=1489; Portugal, n=211). All participants filled the instrument Alcohol, Smoking and Substance Involvement Screening Test. Analyses were performed (Student's t-test, ANOVA and Pearson's correlations) using the Statistical Package Social Science (SPSS) version 22.0. A level of statistical significance of 0.05 was established.

Results

It was observed in both countries higher prevalence in attendance of female participants, married, income between 1 and 2 minimum wage (in Brazil). Considering lifelong use of substances, the Brazilian sample showed 45.5% of tobacco use, 67.6% of use of alcoholic beverages and 8.6% of cannabis use. In Portugal, tobacco (59.3%), alcoholic beverages (88.1%) and cannabis (13.5%). Considering the daily frequency of use in the last three months in Brazil: tobacco (14.7%), alcoholic beverages (2.8%), cannabis (0.7%); and in Portugal: tobacco (22.7%), alcohol (32.7%) and cannabis (0.5%). Individuals classified as “moderate risk” were selected to receive Brief Intervention: in Brazil, tobacco use (score 4-26) 16.6%, alcoholic beverages (score 11-26) 8.8%, cannabis 1.5%; Portugal tobacco use (32.0%), use of alcoholic beverages (19.3%) and cannabis use (12.7%).

Conclusions

It was observed the use of psychoactive substances both countries and the importance of the primary health care in the early detection of health problems associated to the use of those substances. The scenario is responsible for health promoting/protection.

Declarations

Acknowledgements

National Counsel of Technological and Scientific Development/ CNPq, Brazil

Authors’ Affiliations

(1)
Public Health Nursing, Federal University of Rio de Janeiro
(2)
State University of Rio de Janeiro
(3)
Federal University of Rio de Janeiro
(4)
Coimbra Nursing School

References

  1. World Health Organization (WHO): Global status report on alcohol and health 2014. 2014, Genebra : WHOGoogle Scholar
  2. Jomar RT, Abreu AMM, Griep RH: Caracterizaíão do consumo de álcool de uma populaíão adscrita à estratégia Saúde da Família. Esc Anna Nery. 2014, 18 (1): 96-100.View ArticleGoogle Scholar
  3. ONU: United Nations Office On Drugs And Crime/Unodc. World Drug Report. 2013, United Nations, New YorkGoogle Scholar
  4. Carlini EA, Galduroz JC, Noto AR, Nappo SA: II Levantamento domiciliar sobre o uso de drogas psicotrópicas no Brasil: estudo envolvendo as 108 maiores cidades do país - 2005. 2007, Brasilia (DF): Secretaria Nacional AntidrogasGoogle Scholar
  5. Ministério da Saúde (BR): Política do Ministério da Saúde para a ateníão integral a usuários de álcool e outras drogas. 2004, Brasília (DF)Google Scholar
  6. Babor TH, Higgins-Biddle JC, Saunders JB, Monteiro MG: AUDIT - Teste de identificaíão de problemas relacionados ao uso de álcool: roteiro para uso em ateníão primária. 2008, Ribeirão Preto(SP): PAI-PADGoogle Scholar

Copyright

© Abreu et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement